Terumo Operating Income 2012-2023 | TRUMY
- Terumo operating income for the quarter ending December 31, 2023 was $M, a 100% decline year-over-year.
- Terumo operating income for the twelve months ending December 31, 2023 was $0.780B, a 11.49% decline year-over-year.
- Terumo annual operating income for 2023 was $0.868B, a 15.87% decline from 2022.
- Terumo annual operating income for 2022 was $1.032B, a 11.59% increase from 2021.
- Terumo annual operating income for 2021 was $0.925B, a 9.12% decline from 2020.
Terumo Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $868 |
2022 | $1,032 |
2021 | $925 |
2020 | $1,018 |
2019 | $960 |
2018 | $977 |
2017 | $712 |
2016 | $678 |
2015 | $617 |
2014 | $653 |
2013 | $644 |
2012 | $801 |
Terumo Quarterly Operating Income (Millions of US $) |
|
---|---|
2023-12-31 | |
2023-06-30 | $216 |
2022-06-30 | $234 |
2021-06-30 | $330 |
2020-06-30 | $168 |
2019-06-30 | $265 |
2018-06-30 | $238 |
2017-06-30 | $210 |
2016-06-30 | $199 |
2015-06-30 | $159 |
2015-03-31 | $1,061 |
2014-12-31 | $1,143 |
2014-09-30 | $1,136 |
2014-06-30 | $155 |
2014-03-31 | $1,221 |
2013-12-31 | $1,192 |
2013-09-30 | $1,161 |
2013-06-30 | $135 |
2013-03-31 | $1,289 |
2012-12-31 | $1,278 |
2012-09-30 | $1,219 |
2012-06-30 | $194 |
2012-03-31 | $1,242 |
2011-12-31 | $1,267 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $24.403B | $6.386B |
Terumo Corporation is engaged in the manufacture and sales of medical products and equipment. The products offered by the Company covers General Hospital Products, Cardiac & Vascular Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo's Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer, electronic sphygmomanometer, urine test strip and leg compression stockings. Terumo Corporation is headquartered in Tokyo, Japan. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $180.765B | 23.67 |
Stryker (SYK) | United States | $129.618B | 31.05 |
Boston Scientific (BSX) | United States | $112.981B | 35.99 |
Medtronic (MDT) | Ireland | $100.927B | 15.11 |
EssilorLuxottica (ESLOY) | France | $99.128B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $40.585B | 0.00 |
Haleon (HLN) | United Kingdom | $37.716B | 27.53 |
ResMed (RMD) | United States | $28.121B | 26.40 |
Koninklijke Philips (PHG) | Netherlands | $22.841B | 18.13 |
Zimmer Biomet Holdings (ZBH) | United States | $22.328B | 14.26 |
Baxter (BAX) | United States | $17.045B | 12.12 |
Insulet (PODD) | United States | $14.134B | 62.67 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.833B | 0.00 |
Demant (WILYY) | Denmark | $9.370B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.790B | 25.48 |
BellRing Brands (BRBR) | United States | $7.453B | 35.06 |
Lantheus Holdings (LNTH) | United States | $5.565B | 13.87 |
GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
Haemonetics (HAE) | United States | $4.215B | 20.79 |
Perrigo (PRGO) | Ireland | $3.501B | 10.61 |
Prestige Consumer Healthcare (PBH) | United States | $3.437B | 16.35 |
Neogen (NEOG) | United States | $3.386B | 32.56 |
ICU Medical (ICUI) | United States | $2.893B | 25.54 |
Envista Holdings (NVST) | United States | $2.858B | 11.79 |
TG Therapeutics (TGTX) | United States | $2.749B | 77.35 |
Green Thumb Industries (GTBIF) | United States | $2.552B | 49.96 |
Agios Pharmaceuticals (AGIO) | United States | $2.448B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.225B | 12.35 |
LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.804B | 0.00 |
Warby Parker (WRBY) | United States | $1.592B | 0.00 |
InMode (INMD) | Israel | $1.532B | 8.14 |
AdaptHealth (AHCO) | United States | $1.332B | 9.90 |
Verano Holdings (VRNOF) | United States | $1.246B | 0.00 |
AtriCure (ATRC) | United States | $1.084B | 0.00 |
Owens & Minor (OMI) | United States | $1.033B | 9.00 |
National Vision Holdings (EYE) | United States | $1.028B | 32.72 |
BioLife Solutions (BLFS) | United States | $0.987B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.679B | 14.46 |
Evolus (EOLS) | United States | $0.679B | 0.00 |
PetIQ (PETQ) | United States | $0.656B | 21.21 |
VAREX IMAGING (VREX) | United States | $0.602B | 14.16 |
Surmodics (SRDX) | United States | $0.599B | 37.54 |
Quanterix (QTRX) | United States | $0.506B | 0.00 |
ZimVie (ZIMV) | United States | $0.498B | 42.44 |
Canopy Growth (CGC) | Canada | $0.491B | 0.00 |
Valneva SE (VALN) | France | $0.488B | 0.00 |
Biote (BTMD) | United States | $0.463B | 10.67 |
Jin Medical (ZJYL) | China | $0.403B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
Cerus (CERS) | United States | $0.325B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.315B | 10.14 |
Zynex (ZYXI) | United States | $0.296B | 40.52 |
MacroGenics (MGNX) | United States | $0.266B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
Aurora Cannabis (ACB) | Canada | $0.252B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.236B | 14.85 |
Omeros (OMER) | United States | $0.235B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
High Tide (HITI) | Canada | $0.178B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
FitLife Brands (FTLF) | United States | $0.153B | 21.76 |
Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.137B | 0.00 |
Veru (VERU) | United States | $0.123B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.104B | 0.00 |
Fonar (FONR) | United States | $0.101B | 10.26 |
Brainsway (BWAY) | Israel | $0.101B | 0.00 |
InterCure (INCR) | Israel | $0.092B | 15.46 |
Cellectar Biosciences (CLRB) | United States | $0.090B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.073B | 4.75 |
MariMed (MRMD) | United States | $0.069B | 0.00 |
Safety Shot (SHOT) | United States | $0.060B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
Modular Medical (MODD) | United States | $0.051B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
Bright Green (BGXX) | United States | $0.048B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
United-Guardian (UG) | United States | $0.041B | 14.90 |
Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
Exagen (XGN) | United States | $0.032B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.021B | 0.00 |
Agape ATP (ATPC) | $0.016B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |